company background image

Sanofi IndiaBSE:500674 Stock Report

Market Cap







16 Oct, 2021


Company Financials
500674 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health6/6

500674 Overview

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India.

Sanofi India Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanofi India
Historical stock prices
Current Share Price₹8,154.60
52 Week High₹7,427.75
52 Week Low₹9,300.00
1 Month Change1.51%
3 Month Change2.40%
1 Year Change-5.99%
3 Year Change37.76%
5 Year Change88.65%
Change since IPO2,229.89%

Recent News & Updates

Shareholder Returns

500674IN PharmaceuticalsIN Market

Return vs Industry: 500674 underperformed the Indian Pharmaceuticals industry which returned 23.5% over the past year.

Return vs Market: 500674 underperformed the Indian Market which returned 68.3% over the past year.

Price Volatility

Is 500674's price volatile compared to industry and market?
500674 volatility
500674 Beta0.42
Industry Beta0.60
Market Beta1

Stable Share Price: 500674 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 500674's weekly volatility (4%) has been stable over the past year.

About the Company

19562,912Rajaram Narayanan

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, allergy and vitamins, and minerals and supplements. The company exports its products to approximately 50 countries, including Germany, the Czech Republic, Australia, the United Kingdom, and Russia.

Sanofi India Fundamentals Summary

How do Sanofi India's earnings and revenue compare to its market cap?
500674 fundamental statistics
Market Cap₹187.80b
Earnings (TTM)₹5.80b
Revenue (TTM)₹29.21b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
500674 income statement (TTM)
Cost of Revenue₹12.89b
Gross Profit₹16.33b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Oct 26, 2021

Earnings per share (EPS)251.89
Gross Margin55.89%
Net Profit Margin19.86%
Debt/Equity Ratio0%

How did 500674 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio


Is Sanofi India undervalued compared to its fair value and its price relative to the market?


Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 500674 (₹8154.6) is trading below our estimate of fair value (₹12518.1)

Significantly Below Fair Value: 500674 is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: 500674 is poor value based on its PE Ratio (32.4x) compared to the Indian Pharmaceuticals industry average (26x).

PE vs Market: 500674 is poor value based on its PE Ratio (32.4x) compared to the Indian market (22.2x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 500674's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: 500674 is overvalued based on its PB Ratio (11.7x) compared to the IN Pharmaceuticals industry average (3.2x).

Future Growth

How is Sanofi India forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanofi India has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Sanofi India performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 500674 has high quality earnings.

Growing Profit Margin: 500674's current net profit margins (19.9%) are higher than last year (14.3%).

Past Earnings Growth Analysis

Earnings Trend: 500674's earnings have grown by 13.4% per year over the past 5 years.

Accelerating Growth: 500674's earnings growth over the past year (30.2%) exceeds its 5-year average (13.4% per year).

Earnings vs Industry: 500674 earnings growth over the past year (30.2%) underperformed the Pharmaceuticals industry 35.8%.

Return on Equity

High ROE: 500674's Return on Equity (36.1%) is considered high.

Financial Health

How is Sanofi India's financial position?

Financial Position Analysis

Short Term Liabilities: 500674's short term assets (₹14.6B) exceed its short term liabilities (₹7.8B).

Long Term Liabilities: 500674's short term assets (₹14.6B) exceed its long term liabilities (₹1.1B).

Debt to Equity History and Analysis

Debt Level: 500674 is debt free.

Reducing Debt: 500674 had no debt 5 years ago.

Debt Coverage: 500674 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 500674 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet


What is Sanofi India current dividend yield, its reliability and sustainability?


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 500674's dividend (1.53%) is higher than the bottom 25% of dividend payers in the Indian market (0.33%).

High Dividend: 500674's dividend (1.53%) is in the top 25% of dividend payers in the Indian market (1.35%)

Stability and Growth of Payments

Stable Dividend: 500674's dividend payments have been volatile in the past 10 years.

Growing Dividend: 500674's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (49.6%), 500674's dividend payments are well covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Rajaram Narayanan (53 yo)





Mr. Rajaram Narayanan serves as Managing Director and Whole Time Director at Sanofi India Ltd. since January 01, 2018 and since October 21, 2015 respectively. Mr. Narayanan serves as Director of Sanofi-Syn...

CEO Compensation Analysis

Compensation vs Market: Rajaram's total compensation ($USD546.38K) is about average for companies of similar size in the Indian market ($USD579.67K).

Compensation vs Earnings: Rajaram's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: 500674's management team is seasoned and experienced (7.8 years average tenure).

Board Members

Experienced Board: 500674's board of directors are considered experienced (3.3 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Sanofi India Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Sanofi India Limited
  • Ticker: 500674
  • Exchange: BSE
  • Founded: 1956
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹187.800b
  • Shares outstanding: 23.03m
  • Website:

Number of Employees


  • Sanofi India Limited
  • Sanofi House
  • CTS No. 117-B, L&T Business Park
  • Mumbai
  • Maharashtra
  • 400072
  • India


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/16 12:01
End of Day Share Price2021/10/14 00:00
Annual Earnings2020/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.